Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Zecher

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Deutsches Arzteblatt International|April 25, 2023
Regional Differences in Waiting Times for Kidney Transplantation in GermanyDaniel Zecher, Ineke Tieken, Josephine Wadewitz, et al.
Kidney International|January 23, 2019
The Case | A 78-year-old woman with acute kidney injury and hemolytic anemiaDaniel Zecher, Bernhard Banas, Maike Büttner-Herold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2009
An innate response to allogeneic nonself mediated by monocytesDaniel Zecher, Nico van Rooijen, David M Rothstein, et al.
Journal of the American Society of Nephrology : JASN|September 24, 2005
G-rich DNA suppresses systemic lupusPrashant S Patole, Daniel Zecher, Rahul D Pawar, et al.
Annals of Transplantation|October 2, 2020
Safe Long-Term Outcome After Kidney Donation in Older Donors: A Single-Center ExperienceAntonia Schuster, Paula Franke, Louisa Steines, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimenDaniel Zecher, Christian Bach, Christoph Staudner, et al.
Frontiers in Medicine|November 25, 2021
Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSAThomas Drasch, Christian Bach, Markus Luber, et al.
Journal of the American Society of Nephrology : JASN|November 11, 2005
Toll-like receptor-7 modulates immune complex glomerulonephritisRahul D Pawar, Prashant S Patole, Daniel Zecher, et al.
Transplantation|August 16, 2022
Impact of Sensitization on Waiting Time Prior to Kidney Transplantation in GermanyDaniel Zecher, Florian Zeman, Thomas Drasch, et al.
HLA|January 10, 2026
Acute Rejection With DSA-Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04-Mismatch Successfully Stabilised With DaratumumabLaura Knödl, Maike Büttner-Herold, Markus Götz, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Deutsches Arzteblatt International|April 25, 2023
Regional Differences in Waiting Times for Kidney Transplantation in GermanyDaniel Zecher, Ineke Tieken, Josephine Wadewitz, et al.
Kidney International|January 23, 2019
The Case | A 78-year-old woman with acute kidney injury and hemolytic anemiaDaniel Zecher, Bernhard Banas, Maike Büttner-Herold, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2009
An innate response to allogeneic nonself mediated by monocytesDaniel Zecher, Nico van Rooijen, David M Rothstein, et al.
Journal of the American Society of Nephrology : JASN|September 24, 2005
G-rich DNA suppresses systemic lupusPrashant S Patole, Daniel Zecher, Rahul D Pawar, et al.
Annals of Transplantation|October 2, 2020
Safe Long-Term Outcome After Kidney Donation in Older Donors: A Single-Center ExperienceAntonia Schuster, Paula Franke, Louisa Steines, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimenDaniel Zecher, Christian Bach, Christoph Staudner, et al.
Frontiers in Medicine|November 25, 2021
Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSAThomas Drasch, Christian Bach, Markus Luber, et al.
Journal of the American Society of Nephrology : JASN|November 11, 2005
Toll-like receptor-7 modulates immune complex glomerulonephritisRahul D Pawar, Prashant S Patole, Daniel Zecher, et al.
Transplantation|August 16, 2022
Impact of Sensitization on Waiting Time Prior to Kidney Transplantation in GermanyDaniel Zecher, Florian Zeman, Thomas Drasch, et al.
HLA|January 10, 2026
Acute Rejection With DSA-Negative Severe Microvascular Inflammation in a Kidney Transplant Recipient With an Isolated DPB1*04-Mismatch Successfully Stabilised With DaratumumabLaura Knödl, Maike Büttner-Herold, Markus Götz, et al.
Pageof 4